Literature DB >> 8828423

Sacrospinous vault suspension and abdominal colposacropexy: success rates and complications.

P J Hardiman1, H P Drutz.   

Abstract

OBJECTIVE: Our purpose was to compare success rates and complications of sacrospinous vault suspension and abdominal colposacropexy. STUDY
DESIGN: A case series is presented of 130 attempted sacrospinous vault suspensions with the Miya hook and 80 cases of abdominal colposacropexy, done in conjunction with other procedures. Patients were assessed 6 weeks and 6 and 12 months after surgery and yearly thereafter.
RESULTS: Sacrospinous vault suspension was completed in 125 women (5 abandoned because of technical difficulty). Abdominal colposacropexy was completed in all 80 women. There was only one intraoperative complication-hemorrhage from the presacral veins during abdominal colposacroplexy. The incidence of postoperative febrile morbidity was 10% after sacrospinous vault suspension and 6% after abdominal colposacropexy. Follow-up ranged from 6 months to 5 years. The incidence of recurrent vault prolapse was 2.4% with sacrospinous vault suspension and 1.3% with abdominal colposacropexy. Demonstrable stress urinary incontinence occurred in one woman after abdominal colposacropexy and in none after sacrospinous vault suspension.
CONCLUSION: Sacrospinous vault suspension and abdominal colposacropexy are associated with a low incidence of intraoperative and postoperative complications and recurrent vault prolapse. Latent stress urinary incontinence may be unmasked, particularly with abdominal colposacropexy, and preoperative urodynamic evaluation is therefore recommended.

Entities:  

Mesh:

Year:  1996        PMID: 8828423     DOI: 10.1053/ob.1996.v175.a74410

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  13 in total

1.  A survey of the complications of vaginal prolapse surgery performed by members of the Society Of Gynecologic Surgeons.

Authors:  Stephen B Young; Ernest I Kohorn; Susan Braz-Martin; Stephen P Baker
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-02-05

Review 2.  Failures and complications in pelvic floor surgery.

Authors:  Kiran Ashok; Eckhard Petri
Journal:  World J Urol       Date:  2011-12-09       Impact factor: 4.226

Review 3.  Systematic review of the efficacy and safety of using mesh in surgery for uterine or vaginal vault prolapse.

Authors:  Xueli Jia; Cathryn Glazener; Graham Mowatt; David Jenkinson; Cynthia Fraser; Christine Bain; Jennifer Burr
Journal:  Int Urogynecol J       Date:  2010-06-15       Impact factor: 2.894

4.  Is standardised vaginal sacrospinous ligament fixation a safe teaching procedure for residents?

Authors:  Axel Sauerwald; Inke Bruns; Barbara Peveling; Hendrik Brunke; Friedrich Wolff
Journal:  Int Urogynecol J       Date:  2010-12-10       Impact factor: 2.894

5.  [Prolapse surgery].

Authors:  K P Jünemann; M Hamann; C Seif
Journal:  Urologe A       Date:  2005-03       Impact factor: 0.639

6.  The need for randomised controlled trials in urogynaecology.

Authors:  Christopher Maher; Bernhard Schuessler
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-06

Review 7.  Abdominal sacral colpopexy: surgical pearls and outcomes.

Authors:  Anthony J Woodruff; Christopher C Roth; J Christian Winters
Journal:  Curr Urol Rep       Date:  2007-09       Impact factor: 3.092

8.  Prosthetic reinforcements: how to manage bladder injuries?

Authors:  I Popovic; P Debodinance; M Cosson; M Boukerrou
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-02-28

9.  Symptomatic and quality of life outcomes after site-specific fascial reattachment for pelvic organ prolapse repair.

Authors:  Abdalla M Fayyad; Emma Redhead; Noveen Awan; Maria Kyrgiou; Sanjeev Prashar; Simon R Hill
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-09-15

Review 10.  Apical prolapse.

Authors:  Matthew D Barber; Christopher Maher
Journal:  Int Urogynecol J       Date:  2013-11       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.